Prognostic and predictive value of FCER1G in glioma outcomes and response to immunotherapy.
Houshi XuQingwei ZhuLan TangJunkun JiangHuiwen YuanAnke ZhangMeiqing LouPublished in: Cancer cell international (2021)
This study demonstrated FCER1G as a novel predictor for clinical diagnosis, prognosis, and response to immunotherapy in glioma patient. Assess expression of FCER1G is a promising method to discover patients that may benefit from immunotherapy.